Innovation Pharmaceuticals Inc. (IPIX: OTCQB) | Pu
Post# of 35800
(Total Views: 32)
Posted On: 01/08/2019 8:45:02 AM
Innovation Pharmaceuticals Inc. (IPIX: OTCQB) | Published Studies Confirm Cisplatin Remains Preferred Chemotherapy Component in Head and Neck Cancer Treatment; Innovation Pharmaceuticals on Target with Clinical Trials of Brilacidin for Preventing Severe Oral Mucositis
(0)
(0)Scroll down for more posts ▼